Trial · NCT07912918
the Effect of Exercise on Sexual Function and Quality of Life in Postpartum Women
NCT07912918, Not applicable, Completed, Isfahan University of Medical Sciences
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. the Effect of Exercise on Sexual Function and Quality of Life in Postpartum Women. Trials, record NCT07912918. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912918
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- the Effect of Exercise on Sexual Function and Quality of Life in Postpartum Women
- NCT number
- NCT07912918
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 72 participants, actual
- Lead sponsor
- Isfahan University of Medical Sciences
- Conditions
- Sexual Health, Quality of Life, Postpartum Women
- Interventions
- Resistance Exercise
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in the Mean score of Female Sexual function index at 8 weeks | Before the intervention begins and after it concludes-which is at the end of the 8th week following the start of the intervention-this questionnaire is completed by participants in both groups as a self-report measure. | The Female Sexual Function Index (FSFI) was first developed and validated by Rosen in 2000 . It consists of 19 items that assess sexual function across six domains over the past four weeks: desire (items 1 and 2), sexual arousal (items 3-6), lubrication (items 7-10), orgasm (items 11-13), pain (items 14-16), and sexual satisfaction (items 17-19). A score of 0 indicates that the individual has not engaged in sexual activity during the past four weeks. The total score for the questionnaire is obtained by summing the scores from all six domains; a higher score indicates better sexual function . |
| Primary | Change from Baseline in the Mean score of Short Form Health Survey (SF-36) at 8 weeks. | Before the intervention begins and after it concludes-which is at the end of the 8th week following the start of the intervention-this questionnaire is completed by participants in both groups as a self-report measure. | The overall score ranges from 0 to 100, where 0 represents the worst state and 100 represents the best.This self-report questionnaire, primarily used to assess quality of life and health, was developed by Ware and Sherbourne. It consists of 36 items and evaluates eight domains: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, mental health, vitality, bodily pain, and general health. Furthermore, the SF-36 provides two summary measures of functioning: the Physical Component Summary (PCS) score, which assesses the physical dimension of health, and the Mental Component Summary (MCS) score, which evaluates the psychosocial dimension of health. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912918
GET https://conductscience.org/api/trials/v1/NCT07912918/registered